What's New on the FDA Drugs Site
June 24, 2015
- Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products Guidance for Industry (PDF - 77KB)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Safety Communication: FDA reporting permanent skin color changes associated with use of Daytrana patch (methylphenidate transdermal system) for treating ADHD
- National Drug Code Directory
- Paragraph IV Patent Certifications (updated)
- Pediatric Medical, Statistical, and Clinical Pharmacology BPCA and PREA Reviews (updated)
.png)
No hay comentarios:
Publicar un comentario